Cite
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs
MLA
Piotr J. Kamola, et al. “Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs.” Molecular Therapy: Nucleic Acids, vol. 8, no. 383–394, Sept. 2017, pp. 383–94. EBSCOhost, https://doi.org/10.1016/j.omtn.2017.07.003.
APA
Piotr J. Kamola, Klio Maratou, Paul A. Wilson, Kay Rush, Tanya Mullaney, Tom McKevitt, Paula Evans, Jim Ridings, Probash Chowdhury, Aude Roulois, Ann Fairchild, Sean McCawley, Karen Cartwright, Nigel J. Gooderham, Timothy W. Gant, Kitty Moores, Stephen A. Hughes, Mark R. Edbrooke, Kenneth Clark, & Joel D. Parry. (2017). Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs. Molecular Therapy: Nucleic Acids, 8(383–394), 383–394. https://doi.org/10.1016/j.omtn.2017.07.003
Chicago
Piotr J. Kamola, Klio Maratou, Paul A. Wilson, Kay Rush, Tanya Mullaney, Tom McKevitt, Paula Evans, et al. 2017. “Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs.” Molecular Therapy: Nucleic Acids 8 (383–394): 383–94. doi:10.1016/j.omtn.2017.07.003.